Evolent Health, Inc. (EVH)
| Market Cap | 1.31B |
| Revenue (ttm) | 2.46B |
| Net Income (ttm) | -104.23M |
| Shares Out | 115.03M |
| EPS (ttm) | -0.91 |
| PE Ratio | n/a |
| Forward PE | 13.85 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,763,602 |
| Open | 11.06 |
| Previous Close | 11.18 |
| Day's Range | 10.96 - 11.52 |
| 52-Week Range | 10.53 - 35.00 |
| Beta | 1.43 |
| Analysts | Strong Buy |
| Price Target | 25.90 (+126.99%) |
| Earnings Date | Feb 20, 2025 |
About EVH
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care wor... [Read more]
Financial Performance
In 2023, Evolent Health's revenue was $1.96 billion, an increase of 45.26% compared to the previous year's $1.35 billion. Losses were -$142.26 million, 642.3% more than in 2022.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for EVH stock is "Strong Buy." The 12-month stock price forecast is $25.9, which is an increase of 126.99% from the latest price.
News
Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1
Longtime CMO Dr. Andrew Hertler to serve as senior advisor and CMO emeritus. WASHINGTON , Dec. 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health o...
Evolent Health: A Shot At Revival After Market Bruising
Evolent Health has seen a significant 50% drop due to a Q3 earnings miss and high medical costs. Despite setbacks, Evolent secured record-breaking new business deals and anticipates over 15% annual re...
Evolent Health, Inc. (EVH) Q3 2024 Earnings Call Transcript
Evolent Health, Inc. (NYSE:EVH) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Seth Frank - V...
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.2% on Friday.
Evolent Announces Third Quarter 2024 Results
Revenue of $621.4 million, an increase of $110.4 million or 21.6%, from the three months ended September 30, 2023. Net loss attributable to common shareholders of Evolent Health, Inc. of $(31.2) milli...
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024
Company to Participate in Upcoming Conferences WASHINGTON , Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex...
Evolent Health Inc (EVH) Stock Price Down 3.2% on Oct 2
Shares of Evolent Health Inc (EVH, Financial) fell 3.20% in mid-day trading on Oct 2. The stock reached an intraday low of $25.76, before recovering slightly to $26.19, down from its previous close of...
Evolent Health: Let The Bidding Begin
Evolent Health is potentially being taken private at a bid of $3.8 billion, offering a 15% upside to the stock at $32 per share. The company's revenue growth rates are expected to decelerate, but pote...
Exclusive: Evolent Health in sale talks after inbound interest, sources say
Evolent Health is in talks with private equity firms and other companies for a potential sale, in a process that kicked off after the healthcare services provider received inbound interest, people fam...
Evolent Health, Inc. (EVH) Q2 2024 Earnings Call Transcript
Evolent Health, Inc. (EVH) Q2 2024 Earnings Call Transcript
Evolent Announces Second Quarter 2024 Results
Revenue of $647.1 million, an increase of $178.0 million or 37.9%, from the three months ended June 30, 2023. Net loss attributable to common shareholders of Evolent Health, Inc. of $(6.4) million and...
Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
Company to Participate in Upcoming Conferences WASHINGTON , July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex...
Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify
Machinify solution seeks to accelerate the efficiency, quality, and clinical value of Evolent's specialty condition management platform through AI-enabled clinical workflow automation Machinify techno...
Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.
Digital cancer care platform Careology and Evolent (NYSE: EVH) to offer an innovative platform to enable cancer navigation Evolent will embed Careology's digital cancer care technology within its comp...
Evolent Announces First Quarter 2024 Results
Revenue of $639.7 million, an increase of $212.0 million or 49.6%, from the three months ended March 31, 2023. Net loss attributable to common shareholders of Evolent Health, Inc. of $(25.2) million a...
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
Company to Participate in Upcoming Conferences WASHINGTON , April 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with comple...
Evolent Health, Inc. (EVH) Q4 2023 Earnings Call Transcript
Evolent Health, Inc. (EVH) Q4 2023 Earnings Call Transcript
Evolent Announces Fourth Quarter and Full Year 2023 Results
WASHINGTON , Feb. 22, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make ...
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors
WASHINGTON , Feb. 14, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make ...
Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024
Company to Participate in Upcoming Investor Conferences WASHINGTON , Jan. 25, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people w...
Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan
WASHINGTON , Dec. 5, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make h...
Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan
WASHINGTON , Dec. 5, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make h...
Evolent Health, Inc. (EVH) Q3 2023 Earnings Call Transcript
Evolent Health, Inc. (NYSE:EVH) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Offic...
Evolent Announces Third Quarter 2023 Results
WASHINGTON , Nov. 2, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make h...
Evolent to release third quarter financial results on Thursday, Nov. 2, 2023, and participate in upcoming investor conferences
WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make ...